Clin Mol Hepatol.  2024 Oct;30(4):1055-1059. 10.3350/cmh.2024.0144.

Examining the therapeutic landscape of beta-blockers in portal hypertension

Affiliations
  • 1Hospital Santa Creu and Sant Pau, Autonomous University of Barcelona, Hospital Sant Pau Biomedical Research Institute (IIB Sant Pau), Barcelona, Spain
  • 2Centre for Biomedical Research in Liver and Digestive Diseases Network (CIBERehd), Barcelona, Spain

Keyword

Clinically significant portal hypertension; Beta-adrenergic blockers; Liver cirrhosis; Primary prevention
Full Text Links
  • CMH
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr